0000899243-19-025494.txt : 20191010 0000899243-19-025494.hdr.sgml : 20191010 20191010214434 ACCESSION NUMBER: 0000899243-19-025494 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191007 FILED AS OF DATE: 20191010 DATE AS OF CHANGE: 20191010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ray Nitya G. CENTRAL INDEX KEY: 0001709522 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 191146965 MAIL ADDRESS: STREET 1: 14 BAYBURY COURT CITY: EAST HANOVER STATE: NJ ZIP: 07936 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2019-10-07 2019-10-08 0 0001175680 CytoDyn Inc. CYDY 0001709522 Ray Nitya G. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 0 1 0 0 See Remarks Stock Options (right to buy) 0.39 2019-10-07 4 A 0 187500 0.00 A 2029-10-07 Common Stock 187500 187500 D This report is being filed to correct an inadvertent error, to report the options issued October 7, 2019 as acquired (and not disposed of) in the transaction, in Column 5. The options will vest in twelve equal monthly installments over the one year period commencing on November 7, 2019. Chief Technology Officer Head of Process Sciences, Manufacturing and Supply Chain /s/ Michael D. Mulholland, as attorney-in-fact 2019-10-10